• Anagliptin: From DPP-4 to Vascular Translation

  2026-09-03

  Anagliptin (SK-0403) offers translational researchers a way to connect selective DPP-4 inhibition with vascular physiology. Evidence from rabbit aorta points to Kv channel and SERCA pump involvement, while defining the controls needed to move beyond glycemic endpoints.

• Yeast-Based Exendin-4 Production for Type 2 Diabetes

  2026-09-02

  A 2024 Frontiers in Systems Biology study established chromosomally integrated Saccharomyces cerevisiae as a stable expression platform for Exendin-4, with protein detected at the expected size and verified by immunoassay. The work is an early manufacturing proof of concept rather than a demonstration of clinical efficacy, but it provides a useful foundation for locally scalable production and future type 2 diabetes research.

• Tetracycline for Mechanism-Driven Cell Assays

  2026-09-02

  Tetracycline is more than a broad-spectrum polyketide antibiotic: it can be a carefully controlled reagent for selection, bacterial protein synthesis studies, and assay validation. This guide connects its use to QRICH1–HMGB1 research while defining practical boundaries for hepatocyte and fibrosis experiments.

• Canagliflozin Workflows for Renal Mitochondria

  2026-09-01

  Canagliflozin enables researchers to connect SGLT2 blockade with proximal-tubule mitochondrial structure, respiration, and renal injury phenotypes. This workflow-led guide shows how to build solvent-controlled in vitro and in vivo studies, interpret sex-dependent responses, and troubleshoot common failures in glucose metabolism modulation assays.

• 5-Methyl-CTP in Translational mRNA Design

  2026-09-01

  A mechanistic and strategic view of 5-Methyl-CTP for modified mRNA synthesis, with guidance on benchmarking stability, translation, delivery, and translational readiness.

• CARMIL Membrane-Binding Domain in Actin Assembly

  2026-08-31

  Mooren and colleagues show that the CARMIL membrane-binding domain is not merely a static membrane tether: it recruits capping protein, supports its activation, and can dissociate after capping protein binding. These findings provide a biochemical model for coordinating membrane localization, barbed-end capping, uncapping, and Arp2/3-dependent actin assembly.

• Bedaquiline Workflows for TB and Cancer Research

  2026-08-31

  Bedaquiline connects direct mycobacterial energy disruption with a practical cancer-metabolism workflow. This guide translates its ATP synthase targeting, mitochondrial effects, handling requirements, and host-directed tuberculosis context into reproducible assay decisions.

• Stable Yeast Expression of Exendin-4: Study Analysis

  2026-08-30

  A 2024 Frontiers in Systems Biology study established a proof-of-concept platform for producing Exendin-4 in chromosomally engineered Saccharomyces cerevisiae, alongside recombinant-expression designs in Escherichia coli. Expression at the expected peptide size and immunoassay confirmation support further development, but activity, yield, purification, oral delivery, and safety remain to be demonstrated.

• Zosuquidar: A Transporter Lens on PROTAC Resistance

  2026-08-29

  Zosuquidar (LY335979) is best known as a selective P-glycoprotein modulator, but recent research positions ABCB1 efflux as a broader resistance mechanism affecting targeted protein degraders. This article translates that finding into practical assay decisions for chemotherapy sensitization and PROTAC resistance studies.

• Balsalazide Disodium: Applied Research Workflows

  2026-08-28

  Turn a colon-targeted 5-aminosalicylic acid prodrug into a practical tool for inflammation research, immunology assays, and inflammatory bowel disease models. This guide covers solution preparation, bacterial activation studies, assay controls, comparative design, and troubleshooting for Balsalazide Disodium Dihydrate.

• CHIR 99021 Trihydrochloride in Organoid Design

  2026-08-28

  CHIR 99021 trihydrochloride is a selective GSK-3 inhibitor that can function as a tunable control point in stem-cell and organoid experiments. This guide connects GSK-3 biology with a recent human intestinal organoid strategy and translates the findings into practical assay decisions.

• Bradykinin B2 Receptors in Guinea Pig Ileal Peristalsis

  2026-08-27

  Chan and Rudd showed that bradykinin suppresses the distension-evoked peristaltic reflex in isolated guinea pig ileum through B2 rather than B1 kinin receptors. By combining selective agonists, antagonists, and pressure-threshold measurements, the study distinguished receptor-mediated modulation of coordinated motility from the direct contractile effects previously described for bradykinin.

• LLY-507: From Target Validation to Assay Design

  2026-08-27

  LLY-507 is a highly selective SMYD2 inhibitor for connecting methyltransferase target engagement with cancer phenotypes and fibrotic signaling. This guide focuses on assay architecture, evidence interpretation, and experimental decisions rather than repeating a general product overview.

• Sitagliptin Phosphate Monohydrate Workflows

  2026-08-26

  Use Sitagliptin phosphate monohydrate to separate DPP-4-dependent incretin biology from mechanical gut-sensing pathways in biochemical, cellular, and metabolic models. This practical guide covers assay setup, GLP-1 and GIP measurements, reference-informed comparisons, and troubleshooting for reliable translational data.

• MG-262 and Muscle Proteostasis: Assay Strategy

  2026-08-26

  MG-262 (Z-Leu-Leu-Leu-B(OH)2) provides a reversible way to interrogate proteasome-dependent proteostasis alongside age-sensitive chaperone-mediated autophagy. This guide translates recent skeletal-muscle findings into more discriminating assay design and interpretation.

7891 records 1/527 page Next 12345 下5页 Last page